A study by Twerenbold et al. (26) examined the relationship of eGFR with cTn and found that the proportion of study participants with elevated hs-cTnT values was greater among the ESRD patients compared to those with CKD stages 3–5, although their cTn concentrations were measured using different assays generation to that applied in our study. Here, TNNT2 is linked to chronic kidney disease.